Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication October 1, 2015
- Published online February 1, 2016.
Article Versions
- Latest version (December 15, 2015 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2016
Author Information
- Mark C. Genovese⇑,
- Daniel K. Braun,
- Janelle S. Erickson,
- Pierre-Yves Berclaz,
- Subhashis Banerjee,
- Michael P. Heffernan and
- Hilde Carlier
- From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.
- M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb.
- Address correspondence to Dr. M.C. Genovese, James W. Raitt Professor of Medicine, Co-Chief Division of Immunology and Rheumatology, Stanford University Medical Center, 1000 Welch Road, Suite 203, Palo Alto, California 94304, USA. E-mail: genovese{at}stanford.edu